icon-folder.gif   Conference Reports for NATAP  
 
  EASL 2024
June 5-8, Milan, Italy
Back grey_arrow_rt.gif
 
 
 
Bulevirtide in combination with pegylated interferon
alfa-2a shows a sustained off-treatment response in the liver

 
 
  EASL 2024 June 5-8 Milan Italy
 
Lena Allweiss, Annika Volmari, Dmitry Manuilov, Stephan Urban, Heiner Wedemeyer, Wildaliz Nieves, Jeffrey J. Wallin, Renee-Claude Mercier, Audrey Lau, Maura Dandri

0608241

0608242

0608243

0608244

0608245

0608246

0608247

0608248